Protocol from a randomized clinical trial of multiple pharmacotherapy adaptations based on treatment response in African Americans who smoke is a research paper published in Contemporary Clinical Trials Communications (2022). On theSindex it has a DataRank of 0.293. It has been cited 5 times, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0245
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institutes of Health
Grant: R01 DA046576
National Cancer Institute
Grant: P30 CA168524
National Center for Advancing Translational Sciences
Grant: UL1TR000001
National Institutes of Health
Grant: 1P20GM130414-01
Center for Addiction and Disease Risk Exacerbation
National Institutes of Health
Grant: 3P30CA168524-07S2
Cancer Center Support Grant
National Institutes of Health
Grant: 8UL1TR000001-02
Heartland Institute for Clinical and Translational Research
National Institutes of Health
Grant: 1R01DA046576-01
Individualizing pharmacotherapy: A novel optimization strategy to increase smoking cessation in the African American community.
National Institute on Drug Abuse
Fields of Study
Keywords
Sustainable Development Goals